North America and Europe Onychomycosis (Tinea Unguium) Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023

1 Market Overview

1.1 Onychomycosis (Tinea Unguium) Drug Introduction

1.2 Market Analysis by Type

1.2.1 Oral

1.2.2 External

1.3 Market Analysis by Applications

1.3.1 Age under 18

1.3.2 Age 18-50

1.3.3 Age above 50

1.4 Market Analysis by Countries

1.4.1 United States Status and Prospect (2013-2023)

1.4.2 Canada Status and Prospect (2013-2023)

1.4.3 United Kingdom Status and Prospect (2013-2023)

1.4.4 Germany Status and Prospect (2013-2023)

1.4.5 France Status and Prospect (2013-2023)

1.4.6 Italy Status and Prospect (2013-2023)

1.4.7 Spain Status and Prospect (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Johnson & Johnson

2.1.1 Business Overview

2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 GSK

2.2.1 Business Overview

2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Novartis

2.3.1 Business Overview

2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Valeant Pharma

2.5.1 Business Overview

2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Kaken Pharmaceutical

2.6.1 Business Overview

2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Galderma

2.7.1 Business Overview

2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Xiuzheng Pharmaceutical

2.8.1 Business Overview

2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Letai

2.9.1 Business Overview

2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.9.2.1 Type 1

2.9.2.2 Type 2

2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Qilu Pharmaceutical

2.10.1 Business Overview

2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications

2.10.2.1 Type 1

2.10.2.2 Type 2

2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 North America and Europe Onychomycosis (Tinea Unguium) Drug Market Competition, by Manufacturer

3.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

3.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

3.2.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

3.2.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer (2016-2017)

3.3 North America and Europe Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)

3.4.2 Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share (2016-2017)

3.5 Market Competition Trend

4 North America and Europe Onychomycosis (Tinea Unguium) Drug Market Analysis by Countries/Regions

4.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries/Regions

4.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries/Regions (2013-2018)

4.2.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries/Regions (2013-2018)

4.2.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)

4.3 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue (Value) by Countries (2013-2018)

4.3.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

4.3.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)

5 North America and Europe Market Segmentation Onychomycosis (Tinea Unguium) Drug by Type

5.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)

5.1.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

5.1.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)

5.2 Oral Sales Growth and Price

5.2.1 North America and Europe Oral Sales Growth (2013-2018)

5.2.2 North America and Europe Oral Price (2013-2018)

5.3 External Sales Growth and Price

5.3.1 North America and Europe External Sales Growth (2013-2018)

5.3.2 North America and Europe External Price (2013-2018)

6 North America and Europe Market Segmentation Onychomycosis (Tinea Unguium) Drug by Application

6.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

6.2 Age under 18 Sales Growth (2013-2018)

6.3 Age 18-50 Sales Growth (2013-2018)

6.4 Age above 50 Sales Growth (2013-2018)

7 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

7.1 United States Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

7.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

7.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

7.2.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

7.3 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)

7.3.1 United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

7.3.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

7.4 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

7.4.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

7.4.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

7.5 United States Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

8 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

8.1 United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

8.2 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2016-2017)

8.2.1 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

8.2.2 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

8.3 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)

8.3.1 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

8.3.2 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

8.4 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

8.4.1 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

8.4.2 United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

8.5 United Kingdom Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

9 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

9.1 Canada Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

9.2 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

9.2.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

9.2.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

9.3 Canada "&Sheet1!$B$1&" Sales and Market Share by Application (2013-2018)"

9.3.1 Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

9.3.2 Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

9.4 Canada Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

9.4.1 Canada Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

9.4.2 Canada Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

9.5 Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

10 Germany Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

10.1 Germany Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

10.2 Germany Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

10.2.1 Germany Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

10.2.2 Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

10.3 Germany Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)

10.3.1 Germany Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

10.3.2 Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

10.4 Germany Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

10.4.1 Germany Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

10.4.2 Germany Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

10.5 Germany Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

11 France Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

11.1 France Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

11.2 France Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

11.2.1 France Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

11.2.2 France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

11.3 France "&Sheet1!$B$1&" Sales by Application (2013-2018)"

11.3.1 France Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

11.3.2 France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

11.4 France Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

11.4.1 France Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

11.4.2 France Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer

11.5 France Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

12 Italy Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

12.1 Italy Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

12.2 Italy Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

12.2.1 Italy Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

12.2.2 Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

12.3 Italy Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2013-2018)

12.3.1 Italy Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

12.3.2 Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

12.4 Italy Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

12.4.1 Italy Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

12.4.2 Italy Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

12.5 Italy Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

13 Spain Onychomycosis (Tinea Unguium) Drug Sales, Revenue, by Type, Application and Manufacturers

13.1 Spain Onychomycosis (Tinea Unguium) Drug Revenue, Sales and Growth Rate (2013-2018)

13.2 Spain Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)

13.2.1 Spain Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

13.2.2 Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

13.3 Spain Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

13.3.1 Spain Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

13.3.2 Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

13.4 Spain Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Manufacturer (2016-2017)

13.4.1 Spain Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)

13.4.2 Spain Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)

13.5 Spain Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

14 Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)

14.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)

14.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Countries/Regions (2018-2023)

14.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.2 United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.3 Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.4 Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.5 France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.6 Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.2.7 Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

14.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)

14.3.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)

14.3.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)

14.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)

14.4.1 North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)

14.4.2 North America and Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)

15 Onychomycosis (Tinea Unguium) Drug Manufacturing Cost Analysis

15.1 Onychomycosis (Tinea Unguium) Drug Key Raw Materials Analysis

15.1.1 Key Raw Materials

15.1.2 Price Trend of Key Raw Materials

15.1.3 Key Suppliers of Raw Materials

15.1.4 Market Concentration Rate of Raw Materials

15.2 Proportion of Manufacturing Cost Structure

15.2.1 Raw Materials

15.2.2 Labor Cost

15.2.3 Manufacturing Expenses

15.3 Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

16 Industrial Chain, Sourcing Strategy and Downstream Buyers

16.1 Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis

16.2 Upstream Raw Materials Sourcing

16.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2017

16.4 Downstream Buyers

17 Sales Channel, Distributors, Traders and Dealers

17.1 Sales Channel

17.1.1 Direct Marketing

17.1.2 Indirect Marketing

17.1.3 Marketing Channel Future Trend

17.2 Distributors, Traders and Dealers

18 Research Findings and Conclusion

19 Appendix

19.1 Methodology

19.2 Data Source

Figure Onychomycosis (Tinea Unguium) Drug Picture

Table Product Specifications of Onychomycosis (Tinea Unguium) Drug

Figure North America and Europe Sales Market Share of Onychomycosis (Tinea Unguium) Drug by Types in 2017

Table Types of Onychomycosis (Tinea Unguium) Drug

Figure Oral Picture

Figure External Picture

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications in 2017

Table Applications of Onychomycosis (Tinea Unguium) Drug

Figure Age under 18 Picture

Figure Age 18-50 Picture

Figure Age above 50 Picture

Figure United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure France Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Figure Spain Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) and Growth Rate (2013-2023)

Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Onychomycosis (Tinea Unguium) Drug Type and Applications

Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Novartis Basic Information, Manufacturing Base and Competitors

Table Novartis Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Pharma Basic Information, Manufacturing Base and Competitors

Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Kaken Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Galderma Basic Information, Manufacturing Base and Competitors

Table Galderma Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Xiuzheng Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Letai Basic Information, Manufacturing Base and Competitors

Table Letai Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Type and Applications

Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer (2016-2017)

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Price by Manufacturers (2016-2017)

Figure Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2016

Figure Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017

Figure Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2016

Figure Top 5 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share in 2017

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Countries/Regions (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries (2013-2018)

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2013

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Market Share by Countries in 2017

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue by Countries (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries (2013-2018)

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2013

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Countries in 2017

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Share by Type (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Revenue Share by Type (2013-2018)

Figure North America and Europe Oral Sales Growth (2013-2018)

Figure North America and Europe Oral Price (2013-2018)

Figure North America and Europe External Sales Growth (2013-2018)

Figure North America and Europe External Price (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Share by Application (2013-2018)

Figure North America and Europe Age under 18 Sales Growth (2013-2018)

Figure North America and Europe Age 18-50 Sales Growth (2013-2018)

Figure North America and Europe Age above 50 Sales Growth (2013-2018)

Figure United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table United States Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table United States Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table United States Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table United Kingdom Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table Canada Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure Canada Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table Canada Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure Canada Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table Canada Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table Germany Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table Germany Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table Germany Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure Germany Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table Germany Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure Germany Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table Germany Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure France Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table France Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table France Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table France Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure France Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table France Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure France Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure France Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table France Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table Italy Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table Italy Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table Italy Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure Italy Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table Italy Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure Italy Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table Italy Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure Spain Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate (2013-2018)

Figure Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)

Table Spain Onychomycosis (Tinea Unguium) Drug Sales by Type (2013-2018)

Table Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2013-2018)

Table Spain Onychomycosis (Tinea Unguium) Drug Sales by Application (2013-2018)

Table Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)

Table Spain Onychomycosis (Tinea Unguium) Drug Sales by Manufacturer (2016-2017)

Figure Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2016

Figure Spain Onychomycosis (Tinea Unguium) Drug Sales Market Share by Manufacturer in 2017

Table Spain Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturer (2016-2017)

Figure Spain Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2016

Figure Spain Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Manufacturer in 2017

Table Spain Onychomycosis (Tinea Unguium) Drug Export and Import (2013-2018)

Figure North America and Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Countries/Regions (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Countries/Regions (2018-2023)

Figure United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure United Kingdom Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Figure Spain Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)

Table North America and Europe Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)

Table Sales Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Onychomycosis (Tinea Unguium) Drug

Figure Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug

Figure Onychomycosis (Tinea Unguium) Drug Industrial Chain Analysis

Table Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Manufacturers in 2017

Table Major Buyers of Onychomycosis (Tinea Unguium) Drug

Table Distributors/Traders/ Dealers List